The headline is broadly defensible, but the qualifications matter. Effect sizes vary by population, the strongest claims rest on shorter trials, and credible voices push back on how it's typically framed.
so we've said after our last patient goes in we at least want to have a two and a half year follow-up so that determines that your trial because of course everyone before that already has follow-up and then you add another so we think that we'll have a median follow-up of three and a half to four years and that's really long enough to see the full effect of lipid lowering
Every Sunday: the week’s new conflicts and verdict changes — and nothing else.
Native comments, Twitter mentions, and Reddit threads about this claim — surfaced together so the conversation isn't fragmented across platforms.
Bookmarking — the dossier-vs-overview split is the right call. Most of the time I want overview; sometimes I want receipts.
Would love a "what would change this verdict" RSS feed. Sign me up if it exists.